Albany, NY -- (SBWIRE) -- 08/09/2018 -- The market for preventive healthcare technologies and services is largely driven by the rising public awareness about vaccination and disease management, constructive government policies aimed at the development of healthcare IT, technological upgradation, and growing demand to reduce healthcare costs. The report indicates that a revised cost structure for the healthcare markets in emerging economies is an opportunity worth capitalizing on. However, lack of patient engagement activities, impeding the adoption of preventive healthcare technologies, and high installation and maintenance costs threaten to impede the growth of the global market.
Read Report Overview @ https://www.transparencymarketresearch.com/preventive-healthcare-technologies.html
The preventive healthcare technologies and services market is broadly segmented into prophylaxis, chronic disease management technologies, early detection and screening technologies, and advanced technologies to reduce errors. In 2013, early detection and screening technologies emerged as the leading segment, with personalized medicine as its most prominent sub-segment. However, registering a strong CAGR of 13.0% from 2014 to 2020, advanced technologies to minimize errors will become the fastest developing segment.
The global preventive healthcare technologies and services market is geographically divided into North America, Asia Pacific, Europe, and Rest of the World. North America is the largest as well as the fastest developing regional segment and is fueled by supportive reimbursement policies, growing awareness about preventive healthcare technologies, and the presence of several leading players. Being a global IT hub has also worked in favor of the North America preventive healthcare technologies and services market.
Request for the Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=822
The Asia Pacific and the Rest of the World regional markets, on the other hand, are anticipated to witness sluggish growth during the forecast period owing to the lack of supportive infrastructure that can help support preventive healthcare technologies and services.
The segment of advanced technologies to minimize errors includes companies such as ScriptPro LLc, Lifecom, Inc., and Omnicell, Inc. The segment of early detection and screening includes players such as Myriad Genetics, Inc., U-Systems, Inc., Dilon Technologies, Inc., and Novx Systems. The chronic disease management technologies segment has vendors such as Healthways, Inc., Medtronic, Inc., Alere Inc., and Omron Healthcare, Inc., while the segment of prophylaxis includes companies such as Merck & Co., Sanofi Pasteur MSD, and GlaxoSmithKline plc.
Obtain the Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=822
About Transparency Market Research
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.